A model of hematopoietic development wherein multipotentiality is conserved until segregation of myeloid and lymphoid potential has recently been challenged, proposing that megakaryocyte/erythrocyte (MegE) potential is lost in Flk2/Flt3-expressing early progenitors. Here, we used sensitive in vivo approaches to quantitatively and kinetically assess the MegE potential of hematopoietic stem cells and various Flk2 + early progenitors and compared it with the MegE potential of downstream committed myeloid and lymphoid progenitors and with their ability to give rise to mature myelomonocytic and lymphoid cells. We demonstrate that Flk2 + early progenitors retain MegE potential in vivo both at the population and clonal levels. These results indicate that Flk2 expression by early progenitors is not at the expense of full multipotency and support the current model of hematopoietic development with segregation of myeloid and lymphoid lineages from multipotent progenitors.
A model of hematopoietic development wherein multipotentiality is conserved until segregation of myeloid and lymphoid potential has recently been challenged, proposing that megakaryocyte/erythrocyte (MegE) potential is lost in Flk2/Flt3-expressing early progenitors. Here, we used sensitive in vivo approaches to quantitatively and kinetically assess the MegE potential of hematopoietic stem cells and various Flk2 + early progenitors and compared it with the MegE potential of downstream committed myeloid and lymphoid progenitors and with their ability to give rise to mature myelomonocytic and lymphoid cells. We demonstrate that Flk2 + early progenitors retain MegE potential in vivo both at the population and clonal levels. These results indicate that Flk2 expression by early progenitors is not at the expense of full multipotency and support the current model of hematopoietic development with segregation of myeloid and lymphoid lineages from multipotent progenitors.
INTRODUCTION
Hematopoietic development is one of the most intensely studied systems of cellular differentiation, where multipotent self-renewing hematopoietic stem cells (HSC) give rise to a hierarchy of progenitor populations with more restricted lineage potential, ultimately leading to the production of all types of mature blood cells. Prospective isolation of cellular subsets based on expression of cellsurface markers followed by functional characterization using in vitro and in vivo assays has provided key insights into hematopoietic development (Weissman, 2000) . One model states that only the most primitive long-term reconstituting subset of HSC (LT-HSC) self-renew for life and give rise to short-term reconstituting subsets of HSC (ST-HSC), with limited self-renewal activity, and then to multipotent progenitors (MPP) that do not self-renew (Spangrude et al., 1988; Morrison et al., 1997; Christensen and Weissman, 2001 ). In this model, differentiation progresses with segregation of myeloid and lymphoid lineages through the generation of common myeloid progenitors (CMP) and common lymphoid progenitors (CLP) (Kondo et al., 1997) . Both CLP and CMP undergo further lineage segregation, with CMP giving rise to myelomonocytic progenitors (GMP) and megakaryocyte/erythrocyte progenitors (MEP) that separate granulocyte and macrophage production from red blood cell and platelet production .
In the mouse, multipotent hematopoietic activity is contained in a small fraction of the bone marrow that lacks expression of mature hematolymphoid-associated cellsurface markers (lineage or ''Lin'' markers) and displays high levels of the stem cell-associated markers c-Kit and Sca-1 (Lin À /c-Kit + /Sca-1 + or ''KLS'') (Spangrude et al., 1988; Ikuta and Weissman, 1992) . The KLS fraction can be further subdivided into functionally distinct subpopulations based on the expression levels of the Thy1.1 (Spangrude et al., 1988) , CD4 and Mac-1 (Morrison and Weissman, 1994) , CD34 (Osawa et al., 1996) , Flk2/Flt3 (Adolfsson et al., 2001; Christensen and Weissman, 2001) , and the Slam family (Kiel et al., 2005; Forsberg et al., 2005) of surface molecules. Within the KLS fraction, loss of Thy1.1 and gain of Flk2 expression correlates with decreased self-renewal ability (Adolfsson et al., 2001; Christensen and Weissman, 2001 ) and increased proliferation (Passegué et al., 2005) . Recently, it has been reported that Flk2-expressing KLS cells might not be fully multipotent because they failed to generate significant megakaryocyte (Meg) and erythrocyte (E) progenies in the assays used in those studies Adolfsson et al., 2005) . Conclusions from those reports challenged the current fate map of hematopoietic development and the existence of MPP and CMP populations by suggesting that early progenitor populations might sequentially lose lineage potential as they differentiate from LT-HSC, starting with loss of MegE potential ; also see commentaries by Akashi et al., 2005; Hock and Orkin, 2005 ). An important test for HSC function is their ability to reconstitute the blood system of an irradiated host, including the HSC pool. Commonly, donor cells are distinguished from host cells by transplantation of purified populations into conditioned hosts with an allelic difference in the hematopoietic cell-surface marker CD45, followed by allele-specific antibody labeling (Spangrude et al., 1988) . While all mature myelomonocytic and lymphoid cells express robust CD45 levels, mature cells of the MegE lineage lack CD45 expression, making it difficult to assess directly whether the transplanted cells are capable of forming platelets and red blood cells in vivo. Furthermore, while single-cell assessment of lineage potential is feasible for LT-HSC (Smith et al., 1991; Wagers et al., 2002; Osawa et al., 1996; Adolfsson et al., 2001) , progenitors with lower self-renewal potential give rise to insufficient numbers of progeny for robust single-cell detection in vivo. Thus, as self-renewal ability declines, increasing numbers of input cells are needed to allow detection of progeny. In addition, mature myeloid cells are short lived (days), while a significant fraction of mature lymphocytes are long lived (months to years), enabling easier detection of lymphoid versus myeloerythroid progeny at late time points. Together, these limitations have made it difficult to assess in vivo the full lineage potential of early progenitor cells.
Here , and LMPP retain MegE potential at the population and clonal levels in vivo, readily detectable when sufficient numbers of input cells are provided and when progeny are investigated at the early and late time points. We also established the timecourse of mature cell production by each of these progenitor populations, hence providing the timing required for these early differentiation events in vivo. These results demonstrate that Flk2 expression is not at the expense of full multipotency and support the current model of hematopoietic development with segregation of myeloid and lymphoid lineages from multipotent progenitors.
RESULTS

Tracking the Lineage Potential of Stem and Progenitor Cells
Due to differences in self-renewal ability and proliferation rates, stem and progenitor cells differ considerably in their ability to expand both in vitro and in vivo. To assay the expansion capacity of LT-HSC, ST-HSC F , MPP F , CMP, GMP, and MEP in vitro, cells were grown in liquid media containing cytokines and growth factors promoting myeloerythroid proliferation and differentiation ( Figure 1A These results indicate an inverse correlation between the burst size of each progenitor population and its degree of maturation, which has to be taken into account when investigating lineage potential in vivo. The differentiation potential of each population was also investigated at the single-cell level in methylcellulose media and further confirmed the direct correlation between the time course of differentiation and the developmental stage of the starting population ( Figure S1 ). To circumvent the lack of CD45 expression by mature cells of the MegE lineage, we used b-actin GFP transgenic mice (Wright et al., 2001 ) as a source of donor cells and transplanted purified stem and progenitor populations at various doses into sublethally irradiated (475 rad) congenic wild-type recipient mice ( Figure 1B ). For all experiments cells were double or triple sorted to ensure maximum purity. Since all platelets (Plt) (Nakorn et al., 2003) and nucleated myelomonocytic and lymphoid cells in the peripheral blood (PB) of b-actin GFP mice are positive for GFP ( Figures 1C and 1D ), this assay enabled direct and quantitative in vivo tracking of mature cell production by each transplanted population. The use of sublethal irradiation, as opposed to lethal irradiation, allowed us to follow the kinetics of mature cell production with high resolution, starting within days after transplantation.
Platelet Production
To determine whether Flk2 expression identifies a KLS population lacking MegE potential, we purified in parallel LT-HSC, ST-HSC contribution, consistent with their more limited expansion capacities.
Kinetics of Mature Cell Production
To establish the kinetics of mature cell production from each population, we followed over time the production of donor-derived Plt and nucleated Gr-1/Mac-1 + myelomonocytes, B220 + B cells, and TCR-b + T cells in the PB of the transplanted animals ( Figures 3 and S3 ). Donorderived Plt were first detected at $7-9 days for all transplanted populations, with Plt production from LT-HSC increasing over a 30-day period and then remaining stable ( Figure 3A ). In contrast, Plt production from ST-HSC and disappeared within 16 to 28 days for every cell dose tested ( Figure 3A) .
LT-HSC were the only cells able to provide sustained production of multilineage donor-derived nucleated cells, which emerged in the PB around day 12 and continued to increase beyond 1 month posttransplantation. In contrast, all progenitor populations produced a transient wave of mature cells, which depended on for its amplitude, emergence, and disappearance time the differentiation stage of the input population and on the type of mature cell produced (short-lived myeloid cells or long-lived lymphoid cells) (Figures 3B, 3C and S3) . Hence, ST-HSC F -derived cells emerged by day 9 and reached a plateau by days 16-20 before gradually declining, while both MPP F and LMPP-derived cells emerged (day 7) and peaked (days 12-16) a few days earlier before declining. In all cases, myelomonocytic maturation occurred first ( Figure 3B ). While LT-HSC, and to a lower extent ST-HSC F , sustained durable production of myelomonocytic cells, production from MPP F and LMPP rapidly declined, reaching undetectable levels within $4 weeks posttransplantation, a timing matching Plt disappearance in the same animals ( Figure 3A ). Myelomonocytic cells derived from transplanted CMP/MEP (peaking at day 12) and GMP (peaking at day 9) also did not accumulate and disappeared within 16 to 20 days ( Figures 3B and S3 (Socolovsky et al., 2001) in the bone marrow (BM) and spleen (Sp) of these mice express low levels of GFP ( Figure 4A ). At day 16 posttransplantation, both BM and Sp populations of GFP dull donor-derived erythrocyte precursors were observed in mice transplanted either with 500 LT-HSC, ST-HSC F , MPP F , or LMPP and were absent from mice transplanted with either 10,000 GMP (data not shown) or CLP ( Figure 4B ). While these erythrocyte precursors stably persisted in LT-HSC-and, for shorter times, ST-HSC Ftransplanted mice, they were only transiently found in MPP F -and LMPP-transplanted mice and disappeared by day 49 ( Figure S4) , and LMPP to give rise to erythrocytes in vivo, we used conventional spleen colony-forming-unit (CFU-S) assays in lethally irradiated mice. Similar to previous results (Na Nakorn et al., 2002) , only mice transplanted with 500 CMP/MEP had visible CFU-S by day 8 ($1/24 frequency), while mice transplanted with 500 GMP did not develop spleen colonies at any time point ( Figure 5A ). Mice transplanted with 100 LT-HSC or ST-HSC F had no obvious CFU-S until day 12 ($1/33 and $1/18 frequencies, respectively), while mice transplanted with either 100 or 500 MPP F or 500 LMPP had by day 10 readily detectable CFU-S, which were more numerous and larger by day 12 ( Figure 5A and data not shown). MPP F gave rise to CFU-S with a frequency of $1/78 and LMPP with a frequency of $1/230 in our assay, which is below the frequency of 1/85 previously reported for this population at day 11 Figure S5 ). Radioprotection analysis also indicates that ST-HSC F radioprotected as efficiently as LT-HSC at the 500 cell dose, while MPP F and LMPP, though with decreasing potency, were more efficient than CMP/MEP at providing radioprotection ( Figure S6 ).
Together, these results demonstrate that Flk2 + KLS cells are capable of robust erythropoiesis and megakaryopoiesis in vivo both at the population and clonal levels.
Short-Term Repopulation Kinetics
We also followed the emergence of GFP 
EpoR, TpoR, and IL3R Gene Expression
We then analyzed these populations by quantitative RT-PCR for the expression levels of the two major receptors associated with MegE development: the erythropoietin receptor (EpoR) and the thrombopoietin receptor (TpoR) (Figure 6 ). The highest levels of EpoR mRNA expression were found in MEP, with LT-HSC displaying an $5-fold lower level, similar to levels reported in CMP (Terskikh et al., 2003) . Although expressed at lower levels than in LT-HSC, EpoR mRNA was detectable in ST-HSC F ($14-fold lower), MPP F ($45-fold lower), and LMPP ($65-fold lower) and to levels much higher than in populations that did not undergo MegE differentiation such as mature granulocytes ($220-fold lower) and B lymphocytes (undetectable). In agreement with previous reports, LT-HSC expressed TpoR mRNA at higher levels than MEP (Terskikh et al., 2003) . While slightly decreased in ST-HSC F ($3-fold lower), MPP F ($5-fold lower), and LMPP ($7-fold lower) compared to LT-HSC, TpoR expression was much higher in those populations than in granulocytes ($700-fold lower) and B lymphocytes (undetectable). Similarly, ST-HSC F , MPP F , and LMPP expressed higher levels of GM-associated receptors IL3R, GM-CSFR, G-CSFR, and M-CSFR than mature cell populations, even to slightly higher levels than in LT-HSC ( Figure 6B and data not shown). Together, these results indicate that Flk2 + KLS cells express at the population level the appropriate myeloid gene programs to undergo both MegE and GM differentiation, and while the transcript levels of some of the MegE regulators are lower than in LT-HSC, they appear to be sufficient for their in vivo MegE potential.
DISCUSSION
A thorough understanding of the lineage potential of each subset of hematopoietic stem and progenitor populations is critical in establishing an accurate map of cell-fate determination during hematopoietic development. A controversy exists as to whether multipotentiality is conserved until segregation of myeloid and lymphoid potential, or whether progenitor populations sequentially lose lineage potential when differentiating from LT-HSC, starting with loss of MegE potential. Here, we demonstrate that multipotentiality is retained in the Flk2/Flt3-positive KLS fraction, and that loss of lineage potential occurs later during differentiation into the oligolineage-committed progenitor populations. Moreover, by uncovering differences in the timecourse of mature cell production from LT-HSC and progenitor cells, we provide a temporal component that is of critical importance for the investigation of the lineage potential of these populations in vivo and for comparing findings between laboratories (Figure 7) . Our results differ from those of the Jacobsen group who concluded that the 25% brightest Flk2 + KLS cells (LMPP) lack MegE potential . It is unlikely that the difference in the assessed ability of LMPP to produce erythrocytes and platelets is due to subtle variations in mouse strains or in sorting strategies, as the Jacobsen group previously reported erythroid readout from LMPP in CFU-S assays . Rather, we believe that this discrepancy is due to several important differences in the interpretation of the results and in experimental design, such as the choice of cell doses and timing for the in vitro and in vivo analyses. To obtain a comprehensive assessment of mature cell production in vivo, we compared the engraftment levels of multiple progenitor populations with different lineage potential and burst sizes and titrated the cell dose required to detect their mature progenies. We found a direct correlation between the number of cells needed and the maturation stage of the starting population, indicating that engraftment and lineage potential of progenitor cells have to be investigated with greater cell numbers than LT-HSC. Furthermore, without constant resupply, as for the self-renewing LT-HSC, all mature cells derived from progenitors were exhausted with kinetics that directly depended on the half-life of the mature cells. We found that short-lived myelomonocytic cells, platelets, and erythrocyte progenitors disappear within 1 month posttransplantation, while long-lived lymphoid cells that can give rise to self-renewing progeny (such as memory T and B cells) accumulate and persist for several months. Thus, in contrast to LT-HSC, investigation of lineage potential of progenitor cells has to be performed at several distinct time points to allow optimal detection of their progenies (before 3 weeks for myelopoiesis, after 3 weeks for lymphopoiesis). By isolating stem and progenitor cells from b-actin GFP transgenic mice and by transplanting them at various cell doses into sublethally irradiated mice, we were able to track directly all donor-derived cells (including platelets and erythrocyte precursors, with the exception of RBC) and to follow with high resolution their kinetics of production, starting within days after transplantation. LT-HSC on a cell-by-cell basis, which was considered the result of contamination by low numbers of LT-HSC in the report by Adolfsson et al. (2005) . By investigating the MegE potential of these progenitors within a developmental series (including both less [LT-HSC] and more [CMP/MEP] committed progenitors), we show that this readout indicates true MegE potential from a low burst size population. We ruled out contamination by using highly purified, double or triple sorted populations for all of our assays. While very low numbers of contaminating LT-HSC could be detected in ST-HSC F (<1/800 cells on average), no contaminating LT-HSC or ST-HSC F were observed in MPP F or LMPP by reanalysis of the sorted populations ( Figure S7 ). The differences observed for all of the investigated populations in repopulating kinetics (emergence, peak, and disappearance) also make contamination an unreasonable explanation for our results. Furthermore, the ability of ST-HSC F , MPP F , and LMPP to form CFU-S shows that erythropoietic output is a constant feature of these populations. This also ruled out the possibility that rare-contaminating LT-HSC provide the erythropoietic readout as MPP F , LMPP, and (Figure 7) . It is yet to be determined whether they are heterogeneous and include a subset of more committed lymphoid precursors that lack CFU-S activity, and if so, whether at the clonal level such precursors retain myelomonocytic potential yet have lost MegE potential.
As we show here that Flk2 + KLS cells are fully multipotent, Flk2 expression per se does not appear to be a marker of lymphoid commitment. Flk2
+ KLS cells are promiscuous in terms of gene expression at the population level and coexpress, though at different levels, master transcriptional regulators, signaling molecules, and cellsurface receptors that are known to be specific for and/ or to specify myeloid or lymphoid fates (Forsberg et al., 2005) . This type of promiscuous gene expression might be a defining characteristic of multipotency (Miyamoto et al., 2002) . However, it is possible that Flk2 signaling facilitates lymphoid differentiation prior to commitment to the lymphoid lineage, which is then clearly marked by cell-surface expression of the interleukin-7 receptor (IL7R) (Kondo et al., 1997) . This would be consistent with the phenotype of Flk2 null mice, which have defects primarily in lymphoid cell development but also in myeloid reconstitution (Mackarehtschian et al., 1995) . In aged wild-type mice, KLS cells have defective (but not absent) lymphoid potential upon transplantation and a correlative defect in the numbers of Flk2 + KLS cells (Rossi et al., 2005) . As there are lineage preferences, even at the level of the LT-HSC, during ontogeny (Ikuta et al., 1990; Cumano and Godin, 2001 ) and aging (Rossi et al., 2005) , it is possible that Flk2 + hematopoietic progenitors readout lineage preferences rather than lineage exclusions; however, this is difficult to assess as production of different types of mature progeny peak at distinct time points. It is interesting to note that 500 transplanted MPP F or LMPP produced GFP + donor-derived cells in the same range as 10,000 transplanted CMP/MEP at day 9 (myeloid readout) and 10,000 transplanted CLP at day 20 (lymphoid readout) ( Figure S3) (Forsberg et al., 2005; Lai et al., 2005) , will also be needed to appreciate how lineage segregation and/or lineage exclusion occurs from these multipotent cells.
We and others have previously described KLS subsets of stem and multipotent cells with different marker combinations (Osawa et al., 1996; Goodell et al., 1996; Morrison et al., 1997; Ivanova et al., 2002) , and the relationships between those populations and the ones described here have not yet been fully investigated. Thus, there are a variety of multipotent cells from which progeny could undergo lineage segregation into lymphoid and myeloid pathways. Some latent but normally unused lineage plasticity remains at these early stages of lineage commitment as CLP, pro-T, and some early pro-B cells are able to revert to myeloid fates upon specific transgene expression and transcription factor inactivation or overexpression (Nutt et al., 1999; Kondo et al., 2000; King et al., 2002; Xie et al., 2004) . CMP also display low B cell production in vivo ; Figure S3 ), but further subdivision of this population with additional surface markers, such as Flk2 (D'Amico and Wu, 2003; Nutt et al., 2005) , should provide a refined phenotypic definition of these progenitors. Importantly, we never observed MegE potential without GM potential and vice versa from any of the progenitor populations investigated (except from MEP and GMP), indicating that segregation of MegE and GM potential mainly occurs downstream of the CMP stage as shown previously .
As erythropoiesis (in contrast to lymphopoiesis) is indispensable for the survival of the animal, it is possible that multiple mechanisms exist for rapid production of MegE cells and that LT-HSC give rise to mature RBC and platelets without first differentiating through some or all of the progenitor intermediates. Although this is an important question, we are not aware of assays that allow a rigorous assessment of this possibility in vivo. The kinetics of lineage repopulation in both sublethally and lethally irradiated mice argues, at least, for differentiation occurring with sequential maturation. In addition, we found a direct correlation between the degree of commitment of the progenitor cells and their rapidity to give rise to mature myelomonocytic, B and T cells. The only exception to this temporal pattern is the simultaneous detection of platelets from all the populations with MegE potential. We are currently unable to determine whether this is due to ''short-cutting'' through differentiation steps as proposed by others (Takano et al., 2004) ; to lack of sensitivity of our assay in detecting very small numbers of donor-derived platelets at earlier time points when the levels of host-derived platelets are still high; to differential responses to signals mediating the response to irradiation; or to differential trafficking to niches supporting megakaryopoiesis. Future technical developments allowing the imaging of LT-HSC cell division and subsequent determination of cell fate will be needed to test these alternative models. As the immediate microenvironment plays critical roles in cell-fate determination, to address these questions it will be important to continue to improve the ability to determine the localization of stem and progenitor cells both under steady-state conditions (Kiel et al., 2005) and upon transplantation (Cao et al., 2004) .
In conclusion, our results support a model of hematopoietic development with segregation of myeloid and lymphoid lineage potential from multipotent progenitors (Figure 7) . This model is, by definition, a simplification of complex biological processes, but at the moment it does account for most, if not all, of the differentiation events. It tolerates hematopoietic plasticity in lineage segregation at early stages of commitment, and it accommodates intrinsic lineage preferences during ontogeny and aging. This model will likely evolve further when as of yet unsolved issues and critical questions will be addressed through technical advances allowing the in vivo analysis of clonal progeny for all progenitors, the in vivo tracking of early differentiation events, the identification and characterization of the niches where HSC and progenitors differentiate, and the analysis at the single-cell instead of population level of lineage priming and fate determination.
EXPERIMENTAL PROCEDURES
Mice Four-to eight-week-old b-actin GFP C57Bl/6-Thy1.1 transgenic mice (Wright et al., 2001 ) were used as donors and 8-to 10-week-old congenic C57Bl/6 wild-type mice were used as recipients. All mice were maintained in Stanford University's Research Animal Facility in accordance with Stanford University guidelines.
Flow Cytometry
Staining and enrichment procedures for LT-HSC, ST-HSC F , MPP F , LMPP, CMP, GMP, MEP, and CLP cell sorting and platelet analyses were performed as previously described Christensen and Weissman, 2001; Nakorn et al., 2003; Adolfsson et al., 2005) . Further information on cell preparation and staining procedures can be found in Table S1 . Cell sorting from b-actin GFP C57Bl/6-Thy1.1 transgenic mice was performed on a modified three-laser (488 nm argon, 598 nm dye, 407 nm Krypton) MoFlo hybrid controlled by digital Diva electronics (Cytomation, Becton Dickinson). Each subpopulation was either double or triple sorted and reanalyzed to ensure maximum purity. Donor-derived GFP + cells were analyzed on a two-laser (488 nm argon, 633 nm HeNe) LSR1A (Becton Dickinson). PB GFP + Plt were analyzed using a gain of 8 and a threshold of 0 for the FSC channel.
In Vivo Assays
Transplantations were performed by retro-orbital injection of purified cells. Recipient mice were either sublethally irradiated (475 rad) or lethally irradiated (950 rad, delivered in split dose 3 hr apart) using an X-ray source irradiator and given antibiotic-containing water for at least 6 weeks postirradiation. PB was obtained from tail vein bleeding and collected either into K 2 EDTA-coated collection tubes (Becton Dickinson) for blood parameter analysis or in 4 ml of ACK (150 mM NH 4 Cl/10 mM KHCO 3 ) containing 10 mM EDTA for flow cytometry analysis. Complete blood counts were done using a CELL-DYN 3500 analyzer (Abbot Diagnostic) calibrated for mouse blood samples. CFU-S assays were performed as described (Morrison and Weissman, 1994) and spleens were fixed in Tellyesniczky's solution (4 parts water: 13 ethanol: 2 formaldehyde: 1 glacial acetic acid) to count the nodules. CFU-S per cell population is given as frequency 1/(numbers of injected cells divided by numbers of observed spleen colonies).
In Vitro Assays
For proliferation analysis, cells were cultured in Iscove's modified Dulbecco's media (IMDM) containing 10% FCS, 13 penicillin/streptomycin, 2 mM GlutaMax-1, 0.1 mM nonessential amino acid, 1 mM sodium pyruvate, 50 mM 2-mercaptoethanol and supplemented with SCF (25 ng/ml), Flt3 ligand (25 ng/ml), IL-11 (25 ng/ml), IL-3 (10 ng/ml), Tpo (25 ng/ml), Epo (2.5 U/ml), and GM-CSF (10 ng/ml) (all purchased from Peprotech and R & D). At the indicated time point, aliquots were sampled to count the total number of live cells capable of excluding trypan blue.
Gene Expression Analysis
Total RNA was isolated using Trizol reagent (InVitrogen) from equivalent numbers of cells, digested with DNaseI to remove DNA contamination, and used for reverse-transcription according to the manufacturer's instructions (SuperScript II kit, InVitrogen). QRT-PCR primers were designed using Primer Express software (Applied Biosystems): EpoR (fwd: GGC AGG AGG GAC ACA AAG G; rev: GCA GGT TGC TCA GAA CAC ACT CA), TpoR (fwd: CAA CCA CTC CTA CCT ACC ACT AAG C; rev: AGG AAT GTA TAG GTC TGC AGT AGC A), IL3R (fwd: TGT CTC CAT CCC CCA CTT CTG; rev GGG TAA ACC TCT GAC CTC GAC TTG), and b-actin (fwd: GAC GGC CAA GTC ATC ACT ATT G; rev: GAC GGC CAG GTC ATC ACT ATT G). All reactions were performed in an ABI-7000 sequence detection system using SYBR Green PCR Core reagents and cDNA equivalent of $300 cells per reaction as previously described (Forsberg et al., 2005) . Expression of the b-actin gene was used to normalize the amount of the investigated transcript.
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